| Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma (NCT05235165) | Children's Oncology Group | 2022-04-01 |
| Indo-cyanine Green (ICG) in Paediatric Oncology MIS (NCT04854018) | Birmingham Women's and Children's NHS Foundation Trust | 2021-04-30 |
| Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma (NCT04668300) | M.D. Anderson Cancer Center | 2020-11-26 |
| Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma (NCT02484443) | National Cancer Institute (NCI) | 2016-02-04 |
| Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma (NCT02470091) | Children's Oncology Group | 2015-11-21 |
| Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas (NCT02357810) | Northwestern University | 2015-03-21 |
| Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma (NCT02243605) | National Cancer Institute (NCI) | 2014-12-19 |
| Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma (NCT01886105) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-08-19 |
| Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung (NCT01759303) | Emerald Clinical Inc. | 2013-04-01 |
| Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma (NCT01804374) | Italian Sarcoma Group | 2011-06-01 |
| DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma (NCT01190943) | Children's Oncology Group | 2010-08-06 |
| Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452) | National Cancer Institute (NCI) | 2010-06-01 |
| Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas (NCT01807052) | Children's Oncology Group | 2009-11-01 |
| Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma (NCT01016015) | National Cancer Institute (NCI) | 2009-11-01 |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery (NCT01553539) | Wake Forest University Health Sciences | 2009-10-01 |
| Study of Blood Samples From Patients With Osteosarcoma (NCT00954473) | Children's Oncology Group | 2009-01-01 |
| Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) (NCT00330421) | National Cancer Institute (NCI) | 2006-06-01 |
| Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma (NCT00134030) | Children's Oncology Group | 2005-11-14 |
| Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors (NCT00093821) | National Cancer Institute (NCI) | 2004-09-01 |
| Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma (NCT00023998) | National Cancer Institute (NCI) | 2001-07-01 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (NCT00004241) | National Cancer Institute (NCI) | 1999-10-01 |